Federated Hermes’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-112,028
Closed -$262K 2080
2025
Q3
$262K Sell
112,028
-232,512
-67% -$399K ﹤0.01% 1467
2025
Q2
$524K Buy
344,540
+1,129
+0.3% +$1.76K ﹤0.01% 1325
2025
Q1
$476K Buy
343,411
+196,064
+133% +$418K ﹤0.01% 1317
2024
Q4
$334K Buy
147,347
+146,959
+37,876% +$516K ﹤0.01% 1406
2024
Q3
$1.83K Buy
+388
New +$2.25K ﹤0.01% 1945
2024
Q1
Sell
-132
Closed -$3K 2043
2023
Q4
$3K Buy
132
+74
+128% +$1.24K ﹤0.01% 1903
2023
Q3
$883 Sell
58
-215
-79% -$2.94K ﹤0.01% 2013
2023
Q2
$3.52K Buy
+273
New +$2.96K ﹤0.01% 1943
2022
Q4
Sell
-1,591
Closed -$1K 2170
2022
Q3
$1K Buy
1,591
+434
+38% +$523 ﹤0.01% 2014
2022
Q2
$1K Buy
1,157
+1,008
+677% +$1.43K ﹤0.01% 2027
2022
Q1
$1K Buy
+149
New +$390 ﹤0.01% 2069
2021
Q3
Sell
-126
Closed -$1K 2221
2021
Q2
$1K Buy
+126
New +$1.24K ﹤0.01% 2116
2020
Q2
Sell
-1,681
Closed -$12K 2253
2020
Q1
$12K Buy
+1,681
New +$23K ﹤0.01% 1847

Other funds holding CABA

Federated Hermes's CABA Position: Q4 2025 in Review

Federated Hermes sold out of Cabaletta Bio (CABA) in Q4 2025, closing a stake of 112,028 shares — an estimated $262K sold.

Federated Hermes first reported a position in CABA in Q1 2020 and held it in 13 quarters. The position peaked at $524K in Q2 2025. 95 funds tracked by Wall St. Rank hold CABA as of Q4 2025.

  • Federated Hermes reported no remaining Cabaletta Bio position as of Q4 2025 after selling out during the quarter.
  • Federated Hermes sold 112,028 Cabaletta Bio shares in Q4 2025, an estimated $262K.
  • Federated Hermes first reported a position in Cabaletta Bio in Q1 2020 and held it in 13 quarters.
  • Federated Hermes's Cabaletta Bio position peaked at $524K in Q2 2025.
  • 95 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2025.

Based on Federated Hermes's 13F filing for Q4 2025, filed 12 Feb 2026.